DRUG · Mapped RxNorm record
imatinib mesylate
Normalized identity: imatinib mesylateView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer
NCT00052949
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
laboratory biomarker analysis
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedImatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Recurrent Small Cell Lung Cancerunresolved
Interventions
imatinib mesylateDRUG · verified · RxNorm: imatinib mesylate
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Cancer and Leukemia Group Bcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00052949 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.